Soy Isoflavone in Combination With Radiation Therapy and Cisplatin in SCC of the Head and Neck

NCT02075112 ↗

Phase 1 Completed 24 enrolled Emory University Radiation Therapy Oncology Group · collab

NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to determine if soy supplementation during chemotherapy and radiation therapy will decrease side effects caused by treatment. Long-lasting dry mouth is a side effect of the standard treatment, and we are testing whether soy supplementation during treatment may reduce this symptom and other side effects of chemoradiation.

Timeline

Start: 2013-11
Primary completion: 2019-09
Completion: 2019-09

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Genistein	Other / unclassified	150 mg	—
Background	Cisplatin	Other / unclassified	100 mg/m2	—

Soy Isoflavone in Combination With Radiation Therapy and Cisplatin in SCC of the Head and Neck

Summary

Timeline

Drugs

Indications